Page 2 - Bkr Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Using artificial intelligence, Montréal-based Simmunome aims to help predict whether drug candidates will succeed or fail in clinical trials.

United statesArmstrong muriraNardin nakhlaTheodorus investmentSandpiper venturesFront row venturesAltis labsDeep genomicsValence discoveryFondsd investissement eurêkaBkr capitalAcet capitalClinical trials